NPY and VGF immunoreactivity increased in the arcuate nucleus, but decreased in the nucleus of the Tractus Solitarius, of type-II diabetic patients. - Wikidata - awgldk - TriplyDB

NPY and VGF immunoreactivity increased in the arcuate nucleus, but decreased in the nucleus of the Tractus Solitarius, of type-II diabetic patients.

NPY and VGF immunoreactivity increased in the arcuate nucleus, but decreased in the nucleus of the Tractus Solitarius, of type-II diabetic patients.

http://www.wikidata.org/entity/Q34341752

about

Suprachiasmatic Nucleus Interaction with the Arcuate Nucleus; Essential for Organizing Physiological Rhythms Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation VGF Peptide Profiles in Type 2 Diabetic Patients' Plasma and in Obese Mice.Decreased serotonin transporter immunoreactivity in the human hypothalamic infundibular nucleus of overweight subjects.

P2860

Q29248275-4655A18D-FEA8-441E-98C4-F61D98D56C2D Q35113488-CEED1040-F0F5-4824-B3B9-897390A1050E Q35839843-94EA13FE-B504-4424-9BC6-8292F3011733 Q39852735-D8E7B0A4-B952-4112-89B8-23FDB719305C

P2860

NPY and VGF immunoreactivity increased in the arcuate nucleus, but decreased in the nucleus of the Tractus Solitarius, of type-II diabetic patients.

http://www.wikidata.org/entity/Q34341752

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@ast

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@en

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@nl

type

label

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@ast

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@en

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@nl

prefLabel

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@ast

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@en

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@nl

P1433

Q34341752-B9EF6264-2A13-45A2-8119-07669F37AD0A

P1476

Q34341752-8C733B9C-D3A4-492B-A3A2-FAC10316BF61

P2093

Q34341752-02EB997E-5437-4819-9608-1C908A9345C9

Q34341752-0FD389D8-70F3-4673-902F-84AEF2823120

Q34341752-3030BB35-D3BA-40A7-8266-4B1B496698C4

Q34341752-41F33543-F727-415A-966F-29421FB9787A

Q34341752-87DE612B-AF54-4D90-BBF2-8612C36776ED

Q34341752-BEA551BD-17D8-473B-ACAE-29D7AC185D86

Q34341752-CC8437DA-3251-4F61-BA9B-F96D437324F4

Q34341752-CE83E621-0610-41F6-B2C7-366490BB49E7

Q34341752-CF5FD5AF-0704-4893-A7BF-0BEDD62B27A8

P2860

Q34341752-08EE25BD-93FE-4C6E-A6FC-9A165559A308

Q34341752-16CE8EE1-7D16-4283-941E-6A91C9784A04

Q34341752-18567E36-4759-4682-92A7-E8C12926A990

Q34341752-192281AF-52FF-456A-9CE1-834E06092750

Q34341752-1CC1ABE3-A105-4809-A6A2-3106D86CBA14

Q34341752-1EF05CAA-703A-459E-9983-677A78305EDE

Q34341752-20715937-E480-4F6E-8A4F-FE3D5B5756D5

Q34341752-2F292076-C55E-49D1-88B8-7D2DDA047765

Q34341752-30D61A38-F719-478C-A696-8544BECB70B0

Q34341752-4B8122A1-43F1-45BE-ABF9-1B2BE80FAACD

P304

Q34341752-0121CCBA-42C5-4281-B41E-A5503979112C

P31

Q34341752-5ED7DB9D-BBCD-465B-BFE8-D1FAB65AD114

P356

Q34341752-40569AC0-66DC-41B9-83BB-832C09925FDE

P407

Q34341752-C0BB7E74-1F59-40E3-AAAE-8EDD4A27381E

P433

Q34341752-9CF5A5BB-D3A8-42EE-8188-F3B2E7A16D48

P478

Q34341752-9107A0E1-1DA5-40A0-BD5E-D5ABD51CA766

P577

Q34341752-04990B86-2967-4379-AD17-0B520F74048A

P5875

Q34341752-A146453D-7A4F-4689-AEAF-21EF741AC70B

P698

Q34341752-7355B939-38D7-465C-9139-6B6B44A80F80

P932

Q34341752-2C6B08AA-6E25-41CB-A5D2-FA7B905F0880

P356

JOURNAL.PONE.0040070

P1433

P1476

NPY and VGF immunoreactivity i ...... of type-II diabetic patients.

@en

P2093

Carolina Escobar

http://www.w3.org/2001/XMLSchema#string

Gian-Luca Ferri

http://www.w3.org/2001/XMLSchema#string

Juan E Olvera Roblera

http://www.w3.org/2001/XMLSchema#string

Laura Chávez-Macías

http://www.w3.org/2001/XMLSchema#string

Maria del Carmen Basualdo

http://www.w3.org/2001/XMLSchema#string

Nadia Saderi

http://www.w3.org/2001/XMLSchema#string

Rafael Avendaño-Pradel

http://www.w3.org/2001/XMLSchema#string

Roberto Salgado-Delgado

http://www.w3.org/2001/XMLSchema#string

Ruud M Buijs

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance

VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity

Aromatic L-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla

VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting

Topography and associations of luteinizing hormone-releasing hormone and neuropeptide Y-immunoreactive neuronal systems in the human diencephalon.

Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons

A brain-liver circuit regulates glucose homeostasis.

Studies on the physiological functions of the melanocortin system.

VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers.

Immunocytochemical localization of pro-opiomelanocortin neurons in human brain areas subserving stimulation analgesia.

P304

e40070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0040070

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229162137

http://www.w3.org/2001/XMLSchema#string

P698

22808091

http://www.w3.org/2001/XMLSchema#string

P932

3394787

http://www.w3.org/2001/XMLSchema#string